These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 4761274)

  • 1. [Understanding of rifamycin S. Reactions of the ansa-rings. Modifications of antibiotics. 8].
    Kump W; Bickel H
    Helv Chim Acta; 1973 Jul; 56(7):2323-47. PubMed ID: 4761274
    [No Abstract]   [Full Text] [Related]  

  • 2. [Understanding of rifamycin S. Reactions of the quinoid nucleus. Modifications of antibiotics. 9].
    Kump W; Bickel H
    Helv Chim Acta; 1973 Jul; 56(7):2348-77. PubMed ID: 4761275
    [No Abstract]   [Full Text] [Related]  

  • 3. [The constitution and configuration of rifamycins B, O, S and SV].
    Oppolzer W; Prelog V
    Helv Chim Acta; 1973 Jul; 56(7):2287-314. PubMed ID: 4761272
    [No Abstract]   [Full Text] [Related]  

  • 4. [Coordination of the 13C-NMR. spectrum of rifamycin S on the basis of selective uncoupling of protons].
    Fuhrer H
    Helv Chim Acta; 1973 Jul; 56(7):2377-86. PubMed ID: 4761276
    [No Abstract]   [Full Text] [Related]  

  • 5. Comprehensive study on structure-activity relationships of rifamycins: discussion of molecular and crystal structure and spectroscopic and thermochemical properties of rifamycin O.
    Bacchi A; Pelizzi G; Nebuloni M; Ferrari P
    J Med Chem; 1998 Jun; 41(13):2319-32. PubMed ID: 9632365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships in open ansa-chain rifamycin S derivatives as inhibitors of HIV-1 reverse transcriptase.
    Bartolucci C; Cellai L; Marzano M; Segre A; Brufani M; Filocamo L; Bianco AD; Guiso M; Brizzi V; Benedetto A
    Farmaco; 1995 Sep; 50(9):587-93. PubMed ID: 7495468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel rifamycins. I-Synthesis and antibacterial activity of 3-hydrazinorifamycin derivatives.
    Marsili L; Franceschi G; Gioia B; Oronzo G; Schioppacassi G; Vigevani A
    Farmaco Sci; 1982 Oct; 37(10):641-50. PubMed ID: 6814953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifamycin biosynthesis: further studies on origin of the ansa chain and chromophore.
    Karlsson A; Sartori G; White RJ
    Eur J Biochem; 1974 Sep; 47(2):251-6. PubMed ID: 4415635
    [No Abstract]   [Full Text] [Related]  

  • 9. Preparation, properties and metabolism of epoxides of -apo-8 -carotenyl acetate.
    Singh H; Cama HR
    Int J Vitam Nutr Res; 1972; 42(3):379-88. PubMed ID: 5086643
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on oxidative modifications of nucleic acid pyrimidine bases.
    Harayama T; Yanada R; Kotoji K; Yoneda F; Taga T; Osaki K; Nagamatsu T
    Nucleic Acids Symp Ser; 1984; (15):1-4. PubMed ID: 6522278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of the 4-oxygenated retinoid metabolites.
    Curley RW; Carson DL
    Drug Des Deliv; 1987 Feb; 1(3):219-24. PubMed ID: 3509334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rifamycin R, a novel metabolite from a mutant of Nocardia mediterranea.
    Martinelli E; Antonini P; Cricchio R; Lancini G; White RJ
    J Antibiot (Tokyo); 1978 Oct; 31(10):949-51. PubMed ID: 711618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Chemistry of Biflavanoid Compounds.
    Locksley HD
    Fortschr Chem Org Naturst; 1973; 30():208-312. PubMed ID: 4617696
    [No Abstract]   [Full Text] [Related]  

  • 14. Constituents of Mammea americana L. IX. Oxidation of mammein and mammeisin.
    Finnegan RA; Merkel KE
    J Pharm Sci; 1972 Oct; 61(10):1603-8. PubMed ID: 5072407
    [No Abstract]   [Full Text] [Related]  

  • 15. Expeditious asymmetric synthesis of a stereoheptad corresponding to the C(19)-C(27)-ansa chain of rifamycins: formal total synthesis of Rifamycin S.
    Turks M; Huang X; Vogel P
    Chemistry; 2005 Jan; 11(2):465-76. PubMed ID: 15551311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New rifamycins. II. Synthesis and biological activity of oximes, hydrazones, and semicarbazones of 3-N-(piperidin-4-one)rifamycin S.
    Marsili L; Franceschi G; Galliani C; Sanfilippo A; Vigevani A
    Farmaco Sci; 1982 Dec; 37(12):781-6. PubMed ID: 7152013
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemical modification of the amide group of rifamycin S.
    Taguchi M; Tsukamoto G
    Chem Pharm Bull (Tokyo); 1985 May; 33(5):2133-6. PubMed ID: 4053236
    [No Abstract]   [Full Text] [Related]  

  • 18. Substituent effects on the solution conformation of rifamycin S.
    Dampier MF; Chen CW; Whitlock HW
    J Am Chem Soc; 1976 Oct; 98(22):7064-9. PubMed ID: 965665
    [No Abstract]   [Full Text] [Related]  

  • 19. Correlation of structure and activity in ansamycins. Molecular structure of sodium rifamycin SV.
    Arora SK
    Mol Pharmacol; 1983 Jan; 23(1):133-40. PubMed ID: 6865897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dipyridyls. 3. Reactions of pyridine-3- and pyridine 4-aldehydes with malononitrile].
    Nantka-Namirski P; Balicki R
    Acta Pol Pharm; 1974; 31(3):271-8. PubMed ID: 4848502
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.